Literature DB >> 15809797

Regional lymph node metastasis from port site implants after laparoscopic surgery.

C P Carmignani1, P H Sugarbaker.   

Abstract

Although overall incidence of laparoscopic port site implants is decreasing, it remains problematic in patients with occult intraabdominal malignancy. Port-site metastases may themselves become the source of new metastases. A 42-year-old man underwent a laparoscopic cholecystectomy for cholelithiasis. One month later, he was diagnosed with a right colon cancer, for which a right colectomy was performed. Eleven months later, a CT scan showed nodules in the umbilicus (one of the original laparoscopic port sites) and behind the right rectus abdominis muscle, adjacent to the deep epigastric vessels. These sites were resected, and histopathology confirmed metastatic adenocarcinoma. The right deep epigastric nodule was reported to be lymph node-positive for metastatic adenocarcinoma. It is probable that dissemination of cancer cells to this lymph node occurred from the port site implants. Presence of metastasis in the lymph nodes draining the abdominal wall should be examined in all patients with port site implants.

Entities:  

Mesh:

Year:  2004        PMID: 15809797     DOI: 10.1007/s00464-003-4538-9

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  14 in total

1.  Wound recurrences following laparoscopic-assisted colectomy for cancer.

Authors:  L Stocchi; H Nelson
Journal:  Arch Surg       Date:  2000-08

2.  An unusual case of port site seeding.

Authors:  S Neuhaus; P Hewett; A Disney
Journal:  Surg Endosc       Date:  2001-05-07       Impact factor: 4.584

Review 3.  Subcutaneous metastasis following laparoscopy in gastric adenocarcinoma.

Authors:  A Cava; J Román; A González Quintela; F Martín; P Aramburo
Journal:  Eur J Surg Oncol       Date:  1990-02       Impact factor: 4.424

Review 4.  Trocar-site metastasis following laparoscopic cholecystectomy for unsuspected carcinoma of the gallbladder. Case report and review of the literature.

Authors:  J C Copher; J J Rogers; M L Dalton
Journal:  Surg Endosc       Date:  1995-03       Impact factor: 4.584

5.  Incidence of port site recurrence after laparoscopic cholecystectomy for preoperatively unsuspected gallbladder carcinoma.

Authors:  K Z'graggen; S Birrer; C A Maurer; H Wehrli; C Klaiber; H U Baer
Journal:  Surgery       Date:  1998-11       Impact factor: 3.982

6.  Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malignant melanoma.

Authors:  J Norman; C W Cruse; C Espinosa; C Cox; C Berman; R Clark; H Saba; K Wells; D Reintgen
Journal:  Am J Surg       Date:  1991-11       Impact factor: 2.565

Review 7.  Managing the peritoneal surface component of gastrointestinal cancer. Part 2. Perioperative intraperitoneal chemotherapy.

Authors:  Paul H Sugarbaker
Journal:  Oncology (Williston Park)       Date:  2004-02       Impact factor: 2.990

Review 8.  Managing the peritoneal surface component of gastrointestinal cancer. Part 1. Patterns of dissemination and treatment options.

Authors:  Paul H Sugarbaker
Journal:  Oncology (Williston Park)       Date:  2004-01       Impact factor: 2.990

9.  Rapid development of malignant metastases in the abdominal wall after laparoscopy.

Authors:  Z Döbrönte; T Wittmann; G Karácsony
Journal:  Endoscopy       Date:  1978-05       Impact factor: 10.093

10.  Tumor implantation after diagnostic laparoscopic biopsy of serous ovarian tumors of low malignant potential.

Authors:  J G Hsiu; F T Given; G M Kemp
Journal:  Obstet Gynecol       Date:  1986-09       Impact factor: 7.661

View more
  2 in total

1.  Port--site metastases following bariatric surgery.

Authors:  Susana Alexandra Rodrigues Graça; Sílvia Costa; Joana Ferreira; Jorge Maciel
Journal:  BMJ Case Rep       Date:  2011-08-04

2.  More Reasonable Animal Model for Study the Effect of Pneumoperitoneum on Abdominal Tumor Cells

Authors:  Lv Qijun; Wang Chongshu
Journal:  Asian Pac J Cancer Prev       Date:  2018-01-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.